<![CDATA[Relapsed/Refractory Multiple Myeloma: Case-Based Discussion — The Comorbid, Higher-Risk Patient, and Program Conclusions]]>

Summary

Dr. Thomas Martin presents a case discussion on treating an older relapsed/refractory multiple myeloma patient with baseline neuropathy and comorbidities being considered for BCMA-directed therapy after prior anti-CD38 therapy progression, highlighting concerns about neurologic toxicity and infection risk.